Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesResearch in context

Summary: Background: UK COVID-19 vaccination policy has evolved to offering COVID-19 booster doses to individuals at increased risk of severe Illness from COVID-19. Building on our analyses of vaccine effectiveness of first, second and initial booster doses, we aimed to identify individuals at incr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Stuart Bedston, Fatima Almaghrabi, Lynsey Patterson, Utkarsh Agrawal, Lana Woolford, Sneha N. Anand, Mark Joy, Anna Crawford, Rosalind Goudie, Rachel Byford, Hoda Abbasizanjani, Deb Smith, Lynn Laidlaw, Ashley Akbari, Christopher Sullivan, Declan T. Bradley, Ronan A. Lyons, Simon de Lusignan, F.D. Richard Hobbs, Chris Robertson, Sir Aziz Sheikh, Ting Shi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-02-01
Edice:	The Lancet Regional Health. Europe
Témata:	COVID-19 Vaccine Hospital admission Vaccine breakthrough Booster dose
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666776223002351
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!